Characteristics | Numbers(interval) | Percentage |
---|---|---|
Age at start ART (years, median)a | 7.7 (1.5–12) | |
<2 years | 2 | 7.7% |
2–4.9 years | 4 | 15.3% |
5–14 years | 20 | 77% |
Sex (male/female) | 16/10 | 61.5%/38.5% |
Reason for ART | ||
WHO stage III-IV | 6 | 36.5% |
Baseline CD4 count <15% | 20 | 63.5% |
Naïve ART regimen | ||
D4T/3TC/NVP (EFV) | 8 | 30.8% |
AZT/3TC/NVP | 18 | 69.2% |
Time on ART (months, median)a,b | 41 (18–72.3) | |
<2 yearsb | 5 | 19.2% |
2 years to <3 yearsb | 7 | 26.9% |
3 years to <4 yearsb | 6 | 23.1% |
>4 yearsb | 8 | 30.8% |
HIV transmission | ||
Blood product or transfusion recipient | 9 | 34.6% |
Mother-to-child transmission | 17 | 65.4% |